Sign Up Today and Learn More About 10X Genomics Stock
Invest in or calculate the value of your shares in 10X Genomics or other pre-IPO companies through EquityZen's platform.
About 10X Genomics Stock
Founded
2012
Headquarters
Pleasanton, CA, US
Total Funding
238M
Industries
Software, Artificial Intelligence, Data and Analytics
10x Genomics is creating revolutionary DNA sequencing technology to help researchers better identify subtle variations that are overlooked by technologies that shred biological samples into tiny fragments before sequencing the short stretches and using computers to assembling them into a genome.
10X Genomics Press Mentions
Stay in the know about the latest news on 10X Genomics
Venrock’s Bryan Roberts on the firm’s new $450 million fund, and where it’s shopping in 2021
TechCrunch • Jan 08, 2021
Why 10X Genomics Has Rallied Post Its IPO
Forbes • Dec 05, 2019
10x Genomics Extends their Application Portfolio
Technology Networks • Jun 23, 2018
With $125M Windfall, 10x Genomics Continues Gold Rush
hcanews.com • May 01, 2018
New Products Posted to GenomeWeb: Qiagen, Fluidigm, 10x Genomics, More
GenomeWeb • Apr 13, 2018
Investors in 10X Genomics
Discover investors in 10X Genomics stock and explore their portfolio companies
10X Genomics Management
Leadership team at 10X Genomics
Co-founder & CEO
Serge Saxonov
Chief Scientific Officer, President, Co-founder
Ben Hindson
Join now and verify your accreditation status to gain access to:
- 10X Genomics current valuation
- 10X Genomics stock price
- Available deals in 10X Genomics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading 10X Genomics Stock
How to invest in 10X Genomics stock?
Accredited investors can buy pre-IPO stock in companies like 10X Genomics through EquityZen funds. These investments are made available by existing 10X Genomics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell 10X Genomics stock?
Shareholders can sell their 10X Genomics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
